Israel Englander Eli Lilly & CO Call Options Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $6.04 Million - $8.08 Million	10,200 Added 4.56%	234,000 $182 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $3.94 Million - $4.64 Million	7,500 Added 3.47%	223,800 $130 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $30.8 Million - $41.2 Million	87,800 Added 68.33%	216,300 $101 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $93,189 - $109,446	300 Added 0.23%	128,500 $44.1 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $26.2 Million - $30.5 Million	81,400 Added 173.93%	128,200 $46.9 Million

Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $7.65 Million - $8.72 Million	-25,800 Reduced 35.54%	46,800 $15.1 Million

3,712

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.